Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Hot Flashes, Hot Flushes, Vasomotor Symptoms

In brief

Vasomotor symptoms (hot flashes, night sweats, VMS) affect up to 65% of breast cancer survivors and negatively impact their quality of life. VMS in Hispanic women are significantly more severe as compared to non-Hispanic Caucasian women. Few effective treatments for VMS are available, especially in the underserved Hispanic and Spanish-speaking populations which is problematic, as Hispanics will comprise 20% of the U.S. population by 2025. Stellate ganglion nerve block (SGB) with local anesthetic, previously performed for chronic pain indications, has shown promise as a potential treatment for menopausal women with VMS in previous clinical trials, but has not been investigated in Hispanic or Spanish-Speaking women with breast cancer in a controlled study.

Key facts

Study ID

NCT03122301

Run by

Northwestern University

People needed

2

Starts

2017-06-01

Expected to finish

2020-07-01

Last updated by the study team

2022-08-09

Who can join

Age: 30 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Hispanic or Spanish speaking women aged 30 to 70 years
• 28 or more reported moderate-to-very severe hot flashes per week
• a minimum of two weeks of VMS diary recording prior to SGB
• current use of tamoxifen, aromatase inhibitors, or SERMs for a breast cancer indication for at last six months
• willingness to undergo fluoroscopy-guided SGB or sham treatment.
• if participant is on an SSRI,SNRI or membrane stabilizer (pregabalin, gabapentin, for example), it must be a stable, unchanged dose for previous 3 months

You may not qualify if…

• conditions that preclude SGB or sham intervention (e.g., anatomic abnormalities of the anterior neck or cervical spine; goiter, cardiac/pulmonary compromise; acute illness/infection; coagulopathy or bleeding disorder; allergic reactions/contraindications to a local anesthetic or contrast dye); pregnancy 2. use of treatments in the past 2 months that can affect VMS (e.g., use of oral or transdermal HT or contraceptives,

Where it is running

• Anesthesiology Pain Medicine Center — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.